Results 201 to 210 of about 10,579 (231)
Some of the next articles are maybe not open access.

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce   +2 more
exaly  

Monoid sublingual immunotherapy.

European annals of allergy and clinical immunology, 2006
Sublingual monoid immunotherapy with monomeric allergoids has been largely used in Europe in the last few years. An open trial of allergoid in tablets has been done in rhinitic patients allergic to house dust mites, grass pollens and Parietaria with clear improvement in clinics and drug consumption scores.
A G, Palma-Carlos   +4 more
openaire   +1 more source

Sublingual immunotherapy☆☆☆★

Journal of Allergy and Clinical Immunology, 1999
Anthony J. Frew   +2 more
openaire   +1 more source

Sublingual immunotherapy

Clinical & Experimental Allergy, 1996
openaire   +1 more source

SUBLINGUAL ALLERGEN IMMUNOTHERAPY

2018
Liječenje alergija nije usmjereno samo protiv simptoma, nego i prema nastanku i prirodnoj progresiji alergija. Sublingvaln alergenska imunoterapija postiže sve te ciljeve te je danas izbor liječenja alergija s vrlo rijetkom pojavom sistemskih nuspojava.
Rožmanić, Vojko, Pelčić, Gordana
openaire  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein   +2 more
exaly  

Sublingual immunotherapy

Journal of Allergy and Clinical Immunology, 2007
openaire   +2 more sources

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Ca-A Cancer Journal for Clinicians, 2018
Pricivel M Carrera   +2 more
exaly  

Home - About - Disclaimer - Privacy